(lp0
S"Rigel Pharmaceuticals Inc: Hits 4-month high Times of India - Mar 8, 2017 ... ** Drug developer's shares rise as much as 14.2 pct to $2.98 - their highest intraday level since mid-November. ** Rigel on Tuesday indicates it is on track to submit a U.S. marketing application in Q1 for its experimental drug fostamatinib to ..."
p1
aS"Why Rigel Pharmaceuticals, Inc. Got Hammered Today Motley Fool - Oct 20, 2016 Rigel Pharmaceuticals  is down 23% at 11:30 a.m. EDT after the company reported a second phase 3 clinical trial testing for its spleen tyrosine kinase inhibitor, fostamatinib, in patients with adult chronic/persistent immune ...Why Rigel Pharma Is Falling - 24/7 Wall St.Stock Update : Here's Why Rigel Pharmaceuticals, Inc. Shares Are ... - Smarter Analyst"
p2
aS'Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year ... PR Newswire  - Feb 28, 2017 SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.  today announced that it will report its fourth quarter and year end 2016 financial results after market close on Tuesday, March 7, 2017.Rigel Pharmaceuticals Inc.  Moves Lower on Volume Spike for February 28 - Equities.com'
p3
aS"Here's Why Rigel Pharmaceuticals, Inc. is Skyrocketing Today Motley Fool - Aug 30, 2016 What: Shareholders of Rigel Pharmaceuticals , a small-cap clinical stage biopharma, are having a pleasant Tuesday.BMO Thinks Rigel's Fostamatinib Market Opportunity Will Be Further Validated - BenzingaWhy Rigel Pharma Is Making a Run - 24/7 Wall St."
p4
aS"Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing ... PR Newswire  - Jan 16, 2017 SOUTH SAN FRANCISCO, Calif., Jan. 16, 2017 /PRNewswire/ -- Rigel Pharmaceuticals  today announced that on January 3, 2017 and January 16, 2017 the Compensation Committee of Rigel's Board of Directors approved the grant of&nbsp;..."
p5
aS"Rigel Restructures to Focus on Fostamatinib Commercialization PR Newswire  - Sep 15, 2016 About Rigel  Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of novel, targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology.Why this Peninsula biotech's layoffs aren't necessarily a bad thing "
p6
aS'Rigel Pharmaceuticals Inc.  Soars 7.46% on March 13 Equities.com - Mar 13, 2017 Rigel Pharmaceuticals Inc.  had a good day on the market for Monday March 13 as shares jumped 7.46% to close at $2.88.'
p7
aS"Rigel Pharmaceuticals Inc.: Rigel Announces Fourth Quarter 2016 and Year End ... The Wall Street Transcript - Mar 7, 2017 'We believe that the favorable safety profile and demonstrated efficacy of fostamatinib may make it an excellent treatment option for patients with chronic ITP,' said Raul Rodriguez, Rigel's president and chief executive officer. 'The company expects ...Rigel Pharmaceuticals Inc.  Plunges 6.99% on March 06 - Equities.com"
p8
aS'The BMO Capital Markets Reaffirms Outperform Rating for Rigel ... Petro Global News 24 - Mar 13, 2017 BMO Capital Markets restated their outperform rating on shares of Rigel Pharmaceuticals, Inc.  in a research report released on Wednesday.HC Wainwright Reiterates Buy Rating for Rigel Pharmaceuticals, Inc.  - BNB Daily Rigel Pharmaceuticals, Inc. : How technical indicators have come out? - Post Analyst'
p9
aS"Top Bullish Mover of Monday: Rigel Pharmaceuticals, Inc.'s  stock price ... WsNews 4investors - Mar 14, 2017 Rigel Pharmaceuticals, Inc.  stock price escalated 7.46% to finalize at $2.88 throughout previous buying and selling session."
p10
a.